Interferon gamma protects against hepatic tumor growth in rats by increasing Kupffer cell tumoricidal activity

Hepatology

Volumn 24, Issue 2, 1996, Pages 374-379

  Karpoff, Howard M ^a   Tung, Cindy ^a   Ng, Bruce ^a   Fong, Yuman ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; RECOMBINANT GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; KUPFFER CELL; LIVER CELL CARCINOMA; LIVER REGENERATION; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; SPLEEN CELL; SPLENECTOMY; TUMOR GROWTH;

EID: 0029742224     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008690407     Document Type: Article

References (37)

1. Fong Y, Blumgart LH, Cohen AM. Surgical treatment of colorectal metastases to the liver. CA Cancer J Clin 1995;45:50-62.
2. Paschis KE, Cantarow A, Stasney J, Hobbs JH, Morris HP. Tumor growth in hepatectomized rats. PAACR 1954;1:37.
3. Paschis KE, Cantarow A, Stasney J, Hobbs JH. Tumor growth in partially hepatectomized rats. Cancer Res 1955;15:579-582.
4. Fisher B, Fisher ER. Effects of partial hepatectomy on hepatic metastases. Cancer 1959;12:929-932.
5. Panis Y, Ribiero J, Chrétien Y, Nordlinger B. Dormant liver metastases, an experimental study. Br J Surg 1994;19:221-233.
6. Naniemo T, Takiechi N, Hata Y, Kobayashi H, Uchino J. Analysis of mechanism of the effect of partial hepatectomy on enhanced growth of liver cancers in rats, experimental analysis of the mechanism of recurrences after liver surgery in human cancers. Acta Hepatol Jpn 1989;30:889-897.
7. Coehn S, Goldrosen M. Modulation of colon-derived experimental hepatic metastases by murine non-parenchymal liver cells. Immunol Invest 1989; 18:351-363.
8. Pearson MJ, Anderson J, Chamberlain J, Bell P. The effect of Kupffer cell stimulation or depression on the development of liver metastases in the rat. Cancer Immunol Immunother 1986;23:214-216.
9. Sato Y, Tsukada K, Matsumoto Y, Abo T. Interferon-γ inhibits liver regeneration by stimulating major histocompatibility complex class II antigen expression in regenerating liver. HEPATOLOGY 1993;18:340-346.
10. Rinehart JJ, Malspeis L, Young D, Neidhart JA. Phase I-II trial of human recombinant interferon gamma in renal cell carcinoma. J Biol Response Mod 1986;5:300-308.
11. Chen JT, Hasumi K. Activation of peritoneal macrophages in patients with gynecological malignancies by sizofiran and recombinant interferon-gamma. Biotherapy 1993;6:189-194.
12. Pujade-Lauraine E, Colobo N, Guastalla J, Namer M, Fumoleau P, Mignot L, Monnier V, et al. Intraperitoneal r-IFN gamma for salvage therapy in ovarian carcinoma [Meeting abstract]. Third International Congress on the Neo-adjuvant Chemotherapy; February 6-9, 1991; Paris, France, p. 68.
13. Pujol JL, Gibney DJ, Su JQ, Maksymiuk AW, Jett JR. Immune response induced in small-cell lung cancer by maintenance therapy with interferon gamma. J Natl Cancer Inst 1993;85:1844-1850.
14. Liénard D, Lejeune FJ, Ewalenko P. In transit metastases of malignant melanoma treated by high dose rTNFα in combination with interferon-γ and melphalan in isolation perfusion. World J Surg 1992;16:234-240.
15. Boue F, Pastran Z, Spielman M, Le Chavalier T, Subriana R, Sevin D, Paoletti C, et al. A phase I trial with recombinant interferon gamma (Roussel Uclaf) in advanced cancer patients. Cancer Immunol Immunother 1990;32:67-70.
16. Lozzio CB, Lozzio BB. Human CML cell line with positive Philadelphia chromosome. Blood 1975;45:321-334.
17. Black PL, Phillips H, Tribble HR, Pennington R, Schneider M, Talmedge JE. Antitumor response to recombinant murine interferon-γ correlates with enhanced immune function of organ-associated, but not recirculating cytolytic T lymphocytes and macrophages. Cancer Immunol Immunother 1993;37:299-309.
18. Higgins GM, Anderson RM. Experimental pathology of liver, restoration of liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
19. Lefreniere R, Rosenberg SA. A novel approach to the generation and identification of experimental hepatic metastases in a murine model. J Natl Cancer Inst 1986;76:309-322.
20. Matsumoto K, Nakamura T. Hepatocyte growth factor, molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncog 1992;3:27-54.
21. Callery MP, Kamei T, Flye MW. Kupffer cell tumor necrosis factor-α production is suppressed during liver regeneration. J Surg Res 1991;50:515-519.
22. Djeu JY, Heinbaugh JA, Holden HT, Herberman HB. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 1979;122:175-181.
23. Fidler IJ, Raz A. The induction of tumoricidal capacities in mouse and rat macrophages by lymphokines. Lymphokines 1981;3:345-349.
24. Wright JA, Turley EA, Greenberg AH. Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy. Crit Rev Oncog 1993;4:473-492.
25. Loizidou M, Lawrance R, Carty N, Cooper A, Alexander P, Taylor I. Macrophage and fibroblast may enhance metastatic growth in liver. Gut 1990; 30:1498-1499.
26. Loizidou M, Carpenter R, Holt S, Lawrie H, Cooper A, Alexander P, Taylor I. The role of fibroblasts in experimental liver metastases. Br J Cancer 1991;64(suppl 15):12.
27. Aggarwal BB, Eessalu TE, Hass PE. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 1985;318:665-667.
28. Zhang F, zur Hausen A, Hoffman R, Grewe M, Decker K. Rat liver macrophages express the 55 kD tumor necrosis factor receptor, modulation by interferon-gamma, lipopolysaccharide and tumor necrosis factor-alpha. Biol Chem Hoppe Seylar 1994;375:249-254.
29. Ruggiero V, Tavernier J, Fiers W, Baglioni C. Induction of the synthesis of tumor necrosis factor receptors by interferon-γ. J Immunol 1986;136: 2445-2450.
30. Armbrust T, Scwogler S, Zohrens G, Ramadori G. C1 esterase inhibitor gene expression in rat Kupffer cells, peritoneal macrophages and blood monocytes, modulation by interferon gamma. J Exp Med 1993;178:373-380.
31. Roland CR, Walp L, Stack RM, Flye MW. Outcome of Kupffer cell antigen presentation to a cloned murine Th1 lymphocyte depends on the inducibility of nitric oxide synthase by IFN-gamma. J Immunol 1994;153:5453-5464.
32. Schuurman B, Heuff G, Beelan RH, Meyer S. Enhanced killing capacity of human Kupffer cells after activation with human granulocyte/macrophage-colony stimulating factor and interferon gamma. Cancer Immunol Immunother 1994;39:179-184.
33. Stukart MJ, Rijnsent A, Roos E. Induction of tumoricidal activity in isolated rat liver macrophages by liposomes containing recombinant rat gamma-interferon supplemented with lipopolysaccharide or muramyldipeptide. Cancer Res 1987;47:2880-2885.
34. Phillips N, Tsao MS. Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative. Cancer Res 1989;49:936-939.
35. Phillips NC. Kupffer cells and liver metastasis. Cancer Metastasis Rev 1989;8:231-252.
36. 2 production by mouse Kupffer cells. Prostaglandins Leukot Essent Fatty Acids 1990;40: 275-279.
37. Blair SL, Karpoff HM, Fong Y. Pretreatment with gamma interferon decreases bacterial translocation after partial hepatectomy. Manuscript in preparation.